International Stem Cell (ISCO) Leases (2019 - 2025)
International Stem Cell (ISCO) has disclosed Leases for 7 consecutive years, with $425000.0 as the latest value for Q3 2025.
- On a quarterly basis, Leases rose 4.42% to $425000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $425000.0, a 4.42% increase, with the full-year FY2024 number at $352000.0, down 36.8% from a year prior.
- Leases was $425000.0 for Q3 2025 at International Stem Cell, down from $504000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $868000.0 in Q4 2021 to a low of $352000.0 in Q4 2024.
- A 5-year average of $627842.1 and a median of $646000.0 in 2023 define the central range for Leases.
- Peak YoY movement for Leases: increased 15.93% in 2022, then crashed 36.8% in 2024.
- International Stem Cell's Leases stood at $868000.0 in 2021, then fell by 16.24% to $727000.0 in 2022, then decreased by 23.38% to $557000.0 in 2023, then plummeted by 36.8% to $352000.0 in 2024, then rose by 20.74% to $425000.0 in 2025.
- Per Business Quant, the three most recent readings for ISCO's Leases are $425000.0 (Q3 2025), $504000.0 (Q2 2025), and $587000.0 (Q1 2025).